INSMED INC INSMED ORD SHS (0JAV.L) Financials
0JAV.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 1.3 billion | 1.6 billion |
2023-06-30 | 1.4 billion | 1.6 billion |
2023-03-31 | 1.5 billion | 1.6 billion |
0JAV.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | -139.2 million | 20.0 million |
2023-06-30 | -127.7 million | 18.4 million |
2023-03-31 | -150.9 million | 16.4 million |
0JAV.L Net Income
No data available :(
0JAV.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 786.0 million | - | - |
2023-06-30 | 917.8 million | - | - |
2023-03-31 | 998.7 million | - | - |
0JAV.L Shares Outstanding
0JAV.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 2.9 million | 109.1 million | - | - |
2023-06-30 | 4.9 million | 197.0 million | - | - |
2023-03-31 | 3.4 million | 127.9 million | - | - |
0JAV.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 79.1 million | 18.0 million |
2023-06-30 | 77.2 million | 17.9 million |
2023-03-31 | 65.2 million | 15.1 million |
0JAV.L
Price: $24.61
52 week price:
Earnings Per Share: -3.78 USD
P/E Ratio: -7.60
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 25.3 million